All Posts: immunotherapy
-
New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients
A new study conducted by an international team of researchers, including clinical investigators at Georgetown Lombardi and John Theurer Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.
Category: News Release
-
Key Studies Conducted at Georgetown Lombardi Lead to Better Treatment for People With Melanoma
Results from a pair of clinical trials published in recent months have changed the treatment landscape for people with advanced melanoma, offering a clearer path for improved survival.
Category: GUMC Stories
-
The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology
Category: News Release
-
Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy
Category: News Release
-
Eliminating the Need for Anti-Rejection Drugs for Transplant Recipients
(January 9, 2022) — Courtney Howard, 43, needed a kidney transplant to save her life and be cured of hereditary polycystic kidney disease. While she knew the kidney transplant was inevitable, what she did not know is that her sister Shannon Walker, who had vowed to provide that kidney when it was needed, would also […]
Category: GUMC Stories
-
Trial Stopped Early: Giving Immunotherapy Before Targeted Rx Improves Survival in Advanced Melanoma
Category: News Release
-
Experimental Drug Boosts Immunotherapy Effectiveness in Pancreatic Cancer in Mice
Category: News Release
-
Boosting Stem Cell Activity Can Enhance Immunotherapy Benefits
Category: News Release
-
Study Shows Why a Common Form of Immunotherapy Fails, and Suggests Solution
Category: News Release
-
Patient Groups Untested in Cancer Immunotherapy Trials Found to Also Benefit
Category: News Release